Manufacturer record
Samarth Life Sciences Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Samarth Life Sciences Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between March 2019 and August 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: INABB23 01, Sterile Noradrenaline Concentrate IP (2mg /1ml) (exp Mar 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Description & Particulate Matter. Listed in the August 2023 alert.
Records by type
2 records linked to Samarth Life Sciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Sterile Noradrenaline Concentrate IP (2mg /1ml) | Batch INABB23 01Mfg Apr 2023 · Exp Mar 2025 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Aug 2023 |
| VIT-K1 (KENADION I) (Phytomenadione Injection I.P.) | Batch IPMDA2808Mfg Jul 2018 · Exp Jun 2020 | Description & Particulate ContaminationDescription | CDL KolkataCDSCO lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.